Oxford, United Kingdom

Jonathan Maelfait

USPTO Granted Patents = 1 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Jonathan Maelfait

Introduction: Jonathan Maelfait, an accomplished inventor based in Oxford, GB, has made significant contributions to the field of immunology through his innovative research and developments. With one patent to his name, his work focuses on enhancing the effectiveness of immune responses through advanced methodologies.

Latest Patents: Jonathan holds a patent for a "Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response." This patent details methods for creating virus-like particles that incorporate immunogenic cyclic dinucleotides, showcasing his commitment to advancing medical science and vaccine research.

Career Highlights: Throughout his career, Jonathan has worked at notable institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. His experiences in these esteemed organizations have equipped him with the expertise and insights necessary to push the boundaries of current scientific understanding.

Collaborations: Jonathan has collaborated with talented individuals like Nicolas Manel and Matteo Gentili. These partnerships have facilitated a rich exchange of ideas and fostered innovative approaches to scientific challenges in the field of immunology.

Conclusion: Jonathan Maelfait’s dedication to his research and his innovative contributions to the development of new immunological methods stand as a testament to the potential of scientific inquiry. With his unique approach and patent, he continues to inspire future generations of inventors and researchers in the pursuit of advancements that can benefit humanity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…